Jacek Szkudlarek

Specialist in radiology

Affiliated departments
Capio Gildhøj

Introduction

2007 - 2019 KAS Herlev, Radiology Dept X, Consultant

2007 - 2007 KAS Herlev, Radiology Dept. X, (Assistant Chief Physician)

2006 - 2006 KAS Herlev, Radiology Dept X, (department physician)

2005 - 2006 Hvidovre Hospital (ward physician)

2004 - 2005 Roskilde Hospital

2003 - 2004 Køge Hospital

2002 - 2003 Rigshospitalet

2001 - 2002 Hvidovre Hospital

2001 - 2001 Bispebjerg Hospital

2000 - 2001 Radiology Department, KAS Glostrup

1999 - 2000 Radiology Department, KAS Glostrup

Education and training

1982 High school graduation

1988 Medical graduate at Akademia Medyczna in Warsaw.

Experience

Department of Surgery, Szpital Srodmiejski in Warsaw

Department of Pediatric Surgery, Szpital Kopernika in Warsaw

Department of Surgery, Frederikshavn Hospital (unclassified)

Kir. Gastroenterologisk Afd., Rigshospitalet (introduction)

Other information

Publications

Szkudlarek J., Elsborg L. Treatment of severe obesity with a highly selective serotonin reuptake inhibitor as a supplement to a low caloric diet. Int J Obesity, 1993; 17: 681-683.

Szkudlarek J., Jeppesen PB, Brøbech PB. Treatment of severe short bowel syndrome with high dose growth hormone and glutamine. (abstract). Gastroenterology, 1998; 114: 699a.

Szkudlarek J, Heydorn, Jeppesen PB, Mortensen PB. Effect of high dose growth hormone and glutamine on intestinal absorption and body composition in short bowel syndrome. A randomized, double blind, cross-over, placebo-controlled study. (abstract). Gastroenterology, 1999; 116: 580a.

Szkudlarek J, Jeppesen PB, Brøbech. Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomized, double blind, crossover, placebo controlled study. Gut. 2000 Aug;47(2):199-205.

Jeppesen PB, Szkudlarek J, Høy C.E., Mortensen PB. Effect of High-Dose Growth Hormone and Glutamine on Body Composition, Urine Creatinine Excretion, Fatty Acid Absorption, and Essential Fatty Acids Status in Short Bowel Patients. A Randomized, Double-blind, Crossover, Placebo-controlled Study. Cand J Gastroenterol 2001;36;48-54.

Szkudlarek J., Elsborg L. Treatment of severe obesity with a highly selective serotonin reuptake inhibitor as a supplement to a low caloric diet. Int J Obesity, 1993; 17: 681-683.

Szkudlarek J., Jeppesen PB, Brøbech PB. Treatment of severe short bowel syndrome with high dose growth hormone and glutamine. (abstract). Gastroenterology, 1998; 114: 699a.

Szkudlarek J, Heydorn, Jeppesen PB, Mortensen PB. Effect of high dose growth hormone and glutamine on intestinal absorption and body composition in short bowel syndrome. A randomized, double blind, cross-over, placebo-controlled study. (abstract). Gastroenterology, 1999; 116: 580a.

Szkudlarek J, Jeppesen PB, Brøbech. Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomized, double blind, crossover, placebo controlled study. Gut. 2000 Aug;47(2):199-205.

Jeppesen PB, Szkudlarek J, Høy C.E., Mortensen PB. Effect of High-Dose Growth Hormone and Glutamine on Body Composition, Urine Creatinine Excretion, Fatty Acid Absorption, and Essential Fatty Acids Status in Short Bowel Patients. A Randomized, Double-blind, Crossover, Placebo-controlled Study. Cand J Gastroenterol 2001;36;48-54.